National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria

Study Overview
=================
Brief Summary
-----------------
National, prospective, multicentric, non-interventional registry-based study, conducted among oncologists, pulmonologists in community and university hospitals, from the public sector in Algeria. The study will collect information on the characteristics, and lung carcinomas patterns of patients whose lung cancer diagnosis was confirmed by a pathologist during the study period.

Detailed Description
-----------------
The study consists of: All patients meeting inclusion/exclusion criteria presenting to their oncologists/pulmonologists for a routine visit during recruitment period will be sequentially asked to participate to the study. The patients who do not consent will only be reported as new case of lung cancer for the incidence study. The patients who consent to participate to the study will perform four in-hospital visits (Inclusion visit, visit at 3, 6 and 12 months). In addition to the 4 visits, a phone contact with the patients every 6 months at years 2,3, 4 and 5 will be done by the investigator or one of his/her authorised representative or the CRO or during a routine visit to the investigator, to check the patient's survival status. THE STUDY DURATION 72 MONTHS

Official Title
-----------------
LuCaReAl: Lung Cancer Registry in Algeria.

Conditions
-----------------
Oncology & Epidemiology & Lung Cancer

Intervention / Treatment
-----------------
* Other: NIS observational stud


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist Aged at least18 years at diagnosis Patients who provide their informed consent form Exclusion Criteria: Patients who did not provide the informed consent form Patients with a mental or psychological disorder according to their treating clinicians
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| lungcancer patients<br>Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist | Other: NIS observational stud<br>* NIS observational study : Epidemiologic registry<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| incidence of lung cancer | incidence of lung cancer, all types, stages and ages combined, in men and women newly diagnosed with lung cancer in Algeria over 12 months of recruitment period | 12 months of recruitment period | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| incidence of newly diagnosed lung cancer | 1) To characterise the incidence of newly diagnosed lung cancer in Algeria in a 12 month period according to patient and disease characteristics (Wilaya, sex, age, lung cancer type, stage disease and smoking status). | 12 month period | 
| survival |  | at 12, 24, 36, 48 and 60 months of follow-up. | 
| quality of life -EORTC QLQ-C30 | To evaluate the quality of life of patients diagnosed with lung cancer in Algeria according to EORTC QLQ-C30 ) | baseline, 3, 6 and 12 months follow-up. | 
| Quality Of Life-EORTC QLQ- LC13 | To evaluate the quality of life of patients diagnosed with lung cancer in Algeria according to EORTC QLQ- LC13 | baseline, 3, 6 and 12 months follow-up. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
lung cancer epidemiology algeria registry